Sort
34,240 grants matching “atherosclerosis”
Genomic and Proteomic Architecture of Atherosclerosis
$2,088,693David M Herrington · Wake Forest University Health Sciences · R01 · FY2020 · HL
CREST-2 Statistical and Data Coordinating Center - SDCC
$2,088,430George Howard · University Of Alabama At Birmingham · U01 · FY2020 · NS
Systematically mapping variant effects for cardiovascular genes
$2,085,976Dan M Roden · Vanderbilt University Medical Center · R01 · FY2022 · HL
Center of Research in Obesity and Cardiovascular Disease (1P20 RR021954-01A1)
$2,084,971Lisa A Cassis · University Of Kentucky · P20 · FY2010 · RR
Genomic and Proteomic Architecture of Atherosclerosis
$2,083,992David M Herrington · Wake Forest University Health Sciences · R01 · FY2019 · HL
INTEGRATIVE NEUROBIOLOGY OF CARDIOVASCULAR REGULATION
$2,082,306Francois M Abboud · University Of Iowa · P01 · FY2008 · HL
CENTER OF RESEARCH IN OBESITY AND CARDIOVASCULAR DISEASE (1P20 RR021954-01A1)
$2,082,003Lisa A Cassis · University Of Kentucky · P20 · FY2008 · RR
Center of Research in Obesity and Cardiovascular Disease (1P20 RR021954-01A1)
$2,082,003Lisa A Cassis · University Of Kentucky · P20 · FY2008 · RR
A Comparative Effectiveness & Long-term Health Study in Wisconsin Smokers
$2,079,714Michael C Fiore · University Of Wisconsin-Madison · R01 · FY2014 · HL
Center of Research in Obesity and Cardiovascular Disease (1P20 RR021954-01A1)
$2,079,402Lisa A Cassis · University Of Kentucky · P20 · FY2012 · GM
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,078,938Christopher K Glass · University Of California, San Diego · P01 · FY2024 · HL
Irreversible Kidney Injury in Renovascular Hypertension
$2,078,762Lilach O Lerman · Mayo Clinic Rochester · P01 · FY2009 · HL
CARDIOVASCULAR BENEFITS OF SOY PHYTOESTROGENS
$2,077,679Wake Forest University Health Sciences · P01 · FY2000 · HL
Protective Mechanisms In Cerebral Ischemia
$2,077,086John Hallenbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Membrane-Mediated Alterations in Diabetes
$2,077,068Richard W Gross · Washington University · P01 · FY2012 · HL
Irreversible Kidney Injury in Renovascular Hypertension
$2,077,066Lilach O Lerman · Mayo Clinic Rochester · P01 · FY2010 · HL
MULTIDISCIPLINARY STRUCTURES AT VASCULAR CELL SURFACES
$2,076,540Timothy A Springer · Boston Children'S Hospital · P01 · FY2013 · HL
Vascular Inflammation and Atherosclerosis
$2,076,482Bradford C Berk · University Of Rochester · P01 · FY2009 · HL
CELLULAR AND MOLECULAR BIOLOGY OF LIPOPROTEIN METABOLISM
$2,075,599Michael C. Phillips · Children'S Hosp Of Philadelphia · P01 · FY2006 · HL
LIPOPROTEIN STRUCTURE/FUNCTION IN CHOLESTEROL METABOLISM
$2,075,084J. David Gladstone Institutes · P01 · FY2001 · HL
Vascular Cell function and Atherosclerosis
$2,074,672Paul E Dicorleto · Cleveland Clinic Lerner Com-Cwru · P01 · FY2006 · HL
Stop Atherosclerosis in Native Diabetics study (SANDS)
$2,074,057Robert E Ratner · Medstar Health Research Institute · U01 · FY2006 · HL
A Comparative Effectiveness & Long-term Health Study in Wisconsin Smokers
$2,073,551Michael C Fiore · University Of Wisconsin-Madison · R01 · FY2015 · HL
Center for Biologic Basis of Oral/Systemic Diseases (CB*
$2,072,905Jeffrey L Ebersole · University Of Kentucky · P20 · FY2007 · RR
SCOR in Molecular Medicine and Atherosclerosis
$2,072,642University Of California San Diego · P50 · FY2004 · HL